<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>114 S31 IS: Medicare Prescription Drug Price Negotiation Act of 2015</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2015-01-06</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">II</distribution-code><congress>114th CONGRESS</congress><session>1st Session</session><legis-num>S. 31</legis-num><current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber><action><action-date date="20150106">January 6, 2015</action-date><action-desc><sponsor name-id="S311">Ms. Klobuchar</sponsor> (for herself, <cosponsor name-id="S313">Mr. Sanders</cosponsor>, <cosponsor name-id="S324">Mrs. Shaheen</cosponsor>, <cosponsor name-id="S362">Mr. Kaine</cosponsor>, <cosponsor name-id="S363">Mr. King</cosponsor>, and <cosponsor name-id="S341">Mr. Blumenthal</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSFI00">Committee on Finance</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title>To amend part D of title XVIII of the Social Security Act to require the Secretary of Health and
			 Human Services to negotiate covered part D drug prices on behalf of
			 Medicare beneficiaries.</official-title></form><legis-body style="OLC"><section id="H886843E13FAF4449AAAE95D4D6191B4D" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the
			 <quote><short-title>Medicare Prescription Drug Price Negotiation Act of 2015</short-title></quote>.</text></section><section id="HA812C80A6E8442AC999967086D96D6A6"><enum>2.</enum><header>Negotiation of
			 lower covered part D drug prices on behalf of Medicare beneficiaries</header><subsection id="HEC1F58FD32744FFA9D1826A1203499CA"><enum>(a)</enum><header>Negotiation by
			 Secretary</header><text>Section 1860D–11 of the Social Security Act (42 U.S.C.
			 1395w–111) is amended by striking subsection (i) (relating to
			 noninterference)
			 and inserting the following:</text><quoted-block id="HA925AF3AC289463B9D4AB3797D1487FC" style="OLC"><subsection id="HC151D361C79C4891AFF204240CA36BFE"><enum>(i)</enum><header>Negotiation of
				Lower Drug Prices</header><paragraph id="HB550ADAE5CFF411BAB6BA0ADFD7BEC55"><enum>(1)</enum><header>In
				general</header><text>Notwithstanding any other provision of law, the Secretary
				shall negotiate with pharmaceutical manufacturers the prices
			 (including
				discounts, rebates, and other price concessions) that may be
			 charged to PDP
				sponsors and MA organizations for covered part D drugs for part D
			 eligible
				individuals who are enrolled under a prescription drug plan or
			 under an MA–PD
				plan.</text></paragraph><paragraph id="H2891009F84B94A209701EBE1F997DEA8"><enum>(2)</enum><header>No change in
				rules for formularies</header><subparagraph id="H29EF1C35F05444D7963083EEF48AF266"><enum>(A)</enum><header>In
				general</header><text>Nothing in paragraph (1) shall be construed to authorize
				the Secretary to establish or require a particular formulary.</text></subparagraph><subparagraph id="HD8C2D6B0C2894EFBB05759BA97FC77FE"><enum>(B)</enum><header>Construction</header><text>Subparagraph
				(A) shall not be construed as affecting the Secretary’s authority
			 to ensure
				appropriate and adequate access to covered part D drugs under
			 prescription drug
				plans and under MA–PD plans, including compliance of such plans
			 with formulary
				requirements under section 1860D–4(b)(3).</text></subparagraph></paragraph><paragraph id="HC08797AA56104DCFA669821915B4E471"><enum>(3)</enum><header>Construction</header><text>Nothing
				in this subsection shall be construed as preventing the sponsor of
			 a
				prescription drug plan, or an organization offering an MA–PD plan,
			 from
				obtaining a discount or reduction of the price for a covered part D
			 drug below
				the price negotiated under paragraph (1).</text></paragraph><paragraph id="H1B96E6F931AB412EBEB24B2CBD99B4EF"><enum>(4)</enum><header>Semi-annual
				reports to congress</header><text>Not later than June 1, 2016, and every 6
				months thereafter, the Secretary shall submit to the Committees on
			 Ways and
				Means, Energy and Commerce, and Oversight and Government Reform of
			 the House of
				Representatives and the Committee on Finance of the Senate a report
			 on
				negotiations conducted by the Secretary to achieve lower prices for
			 Medicare
				beneficiaries, and the prices and price discounts achieved by the
			 Secretary as
				a result of such
				negotiations.</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="HEEC312A3FEBA4C21A371F000743D9AAD"><enum>(b)</enum><header>Effective
			 date</header><text>The amendment made by subsection (a) shall take effect on
			 the date of the enactment of this Act and shall first apply to
			 negotiations and
			 prices for plan years beginning on January 1, 2016.</text></subsection></section></legis-body></bill>


